Today on in-pharmatechnologist.com   Arius and Avid team up Separating mixtures in an NMR machine Combo products need guidelines Pharmaceutical manufacturing: people on the move Medgenics gets (bio)pumping

Related Industry News   Morphosys to exit fee-for-service upon Novartis deal Luminex offers personalised miRNA panels Covance divests cardiac unit Exiqon enters cancer diagnostic field with Oncotech acquisition

		In association with
Breaking News on Pharmaceutical Technology
Daily  Wednesday 05 December 2007		Forward to a colleague

	Application Note Increase your lab productivity with Malvern's New Morphologi G3 particle characterization system The Morphologi® G3 automated particle characterization system from Malvern® Instruments is a new analytical tool that provides high quality, statistically significant particle size and shape information... Click Here Access Full Stories Arius and Avid team up Arius Research and Avid Bioservices have joined forces in the manufacturing and development of an anticancer antibody... Read Separating mixtures in an NMR machine Canadian researchers have devised a method of extracting the complete proton NMR (nuclear magnetic resonance) spectra for a component of a mixture without the need for physical separation... Read Combo products need guidelines The combination products market is zooming ahead, requiring the need to address regulatory challenges, an author of a white paper says... Read Pharmaceutical manufacturing: people on the move Pharmaceutical Profiles, H.D. Smith, Consort Medical, Questcor Pharmaceuticals, and Sunesis Pharmaceuticals have all had people on the move in the world of pharmaceutical manufacturing... Read Medgenics gets (bio)pumping Medgenics' Biopump could be the solution to the issues surrounding protein therapy and is set to take on the $51bn US biopharmaceutical market after raising £3.28m ($6.76m) in funding in its Initial Public... Read
	All News Headlines for: December | November | October
	Application Note Transdermal Sufentanil Licensing Opportunity Aveva's 7-day sufentanil's advanced technology and patient benefits will enable Aveva and its Partner to capture a significant share of the existing $3.9 billion dollar chronic pain market... Click Here
	Related Industry News Morphosys to exit fee-for-service upon Novartis deal Morphosys has landed in the money after scoring a lucrative 10 year antibody development deal with Novartis and as a result, will now place all its eggs in one basket and cut ties with its fee-for-service customers... Read Luminex offers personalised miRNA panels Luminex has expanded its range of FlexmiR miRNA assays with the addition of user-customisable panels that will enable researchers to study only those miRNAs they are interested in... Read Covance divests cardiac unit Covance has announced the $35m sale of its electrocardiogram (ECG) unit in order to focus on its core businesses... Read Exiqon enters cancer diagnostic field with Oncotech acquisition Gene expression analysis expert Exiqon is to pay up to $45m (€30.7m) for diagnostics company Oncotech as a first step towards becoming a world leading miRNA diagnostic manufacturer... Read Weekly Comment No embryo required: human stem cells from the skin A startling breakthrough has allowed scientists to create human stem cells from just reprogrammed skin cells, with no embryo and thus, perhaps no ethical dilemma. Read Seminar Info Premier event for excipient manufacturers and end-users Europe's only dedicated forum on issues affecting the excipients sector is just two months away. Don't miss your chance to hear the latest on key topics such as supply chain integrity, counterfeiting, excipient master files and REACH... Click Here Previous Headlines CMC buys Lilly/ICOS facility Denmark-based CMC Biopharmaceuticals has snapped up Eli Lilly's recently acquired biologics facility for an undisclosed amount... Read Paraytec to lead biopharmaceutical sizing collaboration Paraytec has been chosen to lead a £1m (€1.4m) consortium project to develop new analytical instruments that will detect aggregation in biopharmaceutical processing... Read India's Glenmark pioneering through prioritising preclinical Glenmark is one of a handful of pharma firms in India pushing forward a preclinical programme as a priority... Read Boehringer boosts biopharma base Boehringer Ingelheim has completed a hefty makeover of its biopharmaceutical production plant in Biberach, Germany... Read Almirall takes on big pharma in COPD Spanish firm Almirall is working on a new chronic obstructive pulmonary disease (COPD) treatment combined with a hi-tech easy use inhaler, creating what it hopes will be another competitive product from its in-house... Read Technical / White Papers, Case studies, Web casts Shop floor integration at Novartis Singapore - Case Study Product Information - brochures, Web centers Transdermal Sufentanil Licensing Opportunity - Application Notes Reproducible, homogeneous dry dispersions by the Morphologi® - Application Notes The Safe'n'Sound Passive Safety Device for Prefilled Syringes - Product Presentation A Review of Dissolution tests with the Flow Through Method - Application Notes Product Innovation Alerts - Free of Charge Indicate your research interests and receive alerts on relevant products and market innovations Cleanroom, safety equipment, supplies Contract services (outsourcing) Drug delivery systems Ingredients, excipients and raw materials IT solutions Lab equipment & consumables Packaging machinery & supplies Processing (automation, control, separation...) QA/QC & validation Tabletting, coating & ancillary equipment

	Free Newsletters for Pharmaceuticals Access now !Choose from over 20 industry e-newsletters Access Decision News Media e-newsletters for the food, beverage & nutrition industries, click here
	Forward to a colleague

	To continue to receive this newsletter in your inbox, please add newsletter@In-PharmaTechnologist.com to your address book
	Update preferences | Change your email address | Unsubscribe
	Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback
	© 2007 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com